Indices gain 1% in pullback as IT, pharma stocks lead recovery

HCL Tech rises 5% followed by TechM, Infosys, Sun Pharma

December 22, 2020 10:36 pm | Updated 10:36 pm IST - MUMBAI

The BSE benchmark Sensex settled up by 380.21 points or 0.81% at its all-time closing high of 47,353.75. File

The BSE benchmark Sensex settled up by 380.21 points or 0.81% at its all-time closing high of 47,353.75. File

The equity markets on Tuesday rebounded with a 1% gain following a rise in IT and pharma stocks, a day after benchmark indices crashed 3% on fears of a new strain of the COVID-19 virus.

Buoyed by global cues, the indices opened in positive territory, slumped soon after, but bounced back in the second half. The S&P BSE Sensex rose 453 points or 0.99% to 46,007 points.

All sectoral indices that fell on Monday were back with gains. Top Sensex gainers included HCL Tech that rose 5.09%, Tech Mahindra (4.33%), Infosys (3.78%), PowerGrid (2.67%) and Sun Pharma, which climbed 2.64%. The NSE Nifty 50 index also rose 1.03% to 13,466.30 points.

Sameet Chavan, chief analyst (Technical and Derivatives), Angel Broking said, “The second half turned out to be excellent for the markets; we witnessed V-shaped recovery. IT stocks were the real charioteer and once again came to the rescue.”

“For the next couple of days at least, the index is likely to remain in a slightly wider range before deciding its next path. The ideal range [for the Nifty] would be 13,600 to 13,100, where the lower range should be seen as a sacrosanct support,” he added. Other analysts said the volatility in the market would remain high in the near term due to strict lockdowns and with travel restrictions impacting economic recovery.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.